Summary
G1 Therapeutics
Founded in 2008
Description
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer. G1 is focused on the discovery, development and delivery of i...
Strengths
- G1 Therapeutics has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since G1 Therapeutics was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
G1 Therapeutics's annual revenue
$24160000
Based on Kona Equity data
-
Revenue per employee
$163243
-
Variance of revenue growth
7.77
-
Annual revenue growth since founding
$2411214
-
Revenue growth rate from first known quarter to current
3701.5%
Employee Count
148 employees
-
Employee growth rate from first known quarter to current
19.0%
Executives
Terry Murdock
Senior VP, Development Operations
t**@g1therapeutics.comYili Pritchett
Senior Vice President, Biometrics
y**@g1therapeutics.comJennifer Moses
Chief Financial Officer
j**@g1therapeutics.comJingshan Zhang
Senior Director, Biostatistics
j**@g1therapeutics.comLinda Gambone
Senior Director, Regulatory Affairs
l**@g1therapeutics.comDawn Taylor
Senior Manager, Clinical Data Management
d**@g1therapeutics.comJennifer Adeleye
Director, Clinical Scientist
j**@g1therapeutics.comAnnie Mccoy
Principal Statistical Programmer
a**@g1therapeutics.comWhitney Page
Director, Alliance Management and Chief of Staff
w**@g1therapeutics.comMark Avagliano
Chief Business Officer
m**@g1therapeutics.comDaniel Barnes
Director, Key Customer Marketing
d**@g1therapeutics.comVanessa Dell
Senior Director, Clinical Scientist
v**@g1therapeutics.comRaj Malik
Chief Medical Officer
r**@g1therapeutics.comThomas Aquilina
Vice President, Pharmacovigilance
t**@g1therapeutics.comHolly Kramen
Vice President, Commercial & Counsel
h**@g1therapeutics.comEvan Hicks
Marketing Vice President, Commercial Development
e**@g1therapeutics.comKaren Makhuli
Vice President, Clinical Operations
k**@g1therapeutics.comJulio Ruiz
Associate Director, Statistical Programming
j**@g1therapeutics.comOrlando Mauro
Consultant - Clinical Development
o**@g1therapeutics.comWilliam Roberts
Vice President, Investor Relations & Corporate Communications
w**@g1therapeutics.comJohn Bailey
CEO
j**@g1therapeutics.comDarlene Burns
Director, Key Customer Marketing
d**@g1therapeutics.comSoma Gupta
Chief Commercial Officer
s**@g1therapeutics.comAmanda Jacobson
Director, Clinical Scientist
a**@g1therapeutics.comKaren Deane
Senior Manager, Clinical Operations
k**@g1therapeutics.comRobert Kang
Senior Director, Clinical Data Management
r**@g1therapeutics.comDaniel Ryan
Outsourcing Vice President, Program Management
d**@g1therapeutics.comSymantha Melemed
Vice President, Clinical Development
s**@g1therapeutics.comPhone Therapeutics
Chief Executive Officer
p**@g1therapeutics.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.08 M
-
Daily time
2:07
-
Bounce Rate
58.3 %
Location
Unlock unlimited leads
Similar Companies
Constellation Pharmaceuticals Inc
constellationpharma.com- Founded in 2008
- Location: Cambridge, MA
- Annual Revenue: $28.0M
- Employees: 78
- Constellation Pharmaceuticals is a biopharmaceutical company that develops drugs in the field of epigenetics, focusing on selective regulators of its function. In July 2021, the company was acquired by MorphoSys, a global commercial stage biopharmaceut...
Otonomy
otonomy.com- Founded in 2008
- Location: San Diego, CA
- Annual Revenue: $35.0K
- Employees: 51
- Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve...
ORIC Pharmaceuticals Inc
oricpharma.com- Founded in 1953
- Location: South San Francisco, CA
- Annual Revenue: $26.3M
- Employees: 79
- ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients lives by overcoming resistance in cancer. They develop novel therapies aimed at key tumor dependencies using precision oncology. Their clinical stage pr...
Sierra Oncology
sierraoncology.com- Location: Vancouver, British Columbia
- Annual Revenue: $200.0K
- Employees: 109
- Sierra Oncology is a clinical stage drug development company focused on discovering and developing targeted therapies to treat patients with cancer. We have a diverse pipeline of investigational drugs, as well as a robust preclinical platform, that aim...
Kura Oncology
kuraoncology.com- Founded in 2014
- Location: San Diego, CA
- Annual Revenue: $23.1M
- Employees: 133
- Kura Oncology is a clinical stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small molecule drug candidates target signaling pathways and other drivers of cancer where there is a...
Karyopharm Therapeutics Inc
karyopharm.com- Founded in 2008
- Location: Newton, MA
- Annual Revenue: $157.1M
- Employees: 385
- Karyopharm Therapeutics is an innovation driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer. Karyopharm Therapeutics is a clinical stage p...
Key Information
- Name: G1 Therapeutics
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 28; 283
- NAICS: 3254; 541714
See similar companies
-
By City Durham Small Biotechnology Company in Durham Mid-size Biotechnology Company in Durham Pharmaceuticals in Durham Small Pharmaceuticals in Durham Mid-size Pharmaceuticals in Durham
-
By State NC Small companies in NC Pharmaceuticals in NC Small Pharmaceuticals in NC Mid-size Pharmaceuticals in NC Small Biotechnology Company in NC Mid-size Biotechnology Company in NC
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2008 SIC: 28 SIC: 283 NAICS: 3254 NAICS: 541714 #Medical Testing & Clinical Laboratories #Healthcare #Drug Manufacturing & Research #Pharmaceuticals #Business Services General #Business Services #Organizations General #Education General #Education #Organizations
Frequently Asked Questions
G1 Therapeutics's headquarters are located at 700 Park Offices Drive, Suite 200 Durham, NC 27709.
G1 Therapeutics's official website is g1therapeutics.com
G1 Therapeutics's annual revenue is $24.2 M.
G1 Therapeutics's SIC: 28; 283
G1 Therapeutics's NAICS: 3254; 541714.
G1 Therapeutics has 148 employees
G1 Therapeutics is in the industry of Pharmaceuticals.
